Loading…
Melatonin – a pleiotropic hormone
Melatonin, a tryptophan derivative, is synthesised in mammals mainly in the pineal gland. It coordinates the biological clock by regulating the circadian rhythm. Its production is dependent on light and its concentrations change with age. Thanks to its specific chemical structure, melatonin is capab...
Saved in:
Published in: | Paediatrics and Family Medicine 2016-01, Vol.12 (2), p.127-133 |
---|---|
Main Authors: | , , |
Format: | Article |
Language: | eng ; pol |
Subjects: | |
Citations: | Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c240t-7a081bd33dbd40a688c20c818eba04236a35ee939b1192bb9a8f79c4fc7c90b3 |
---|---|
cites | |
container_end_page | 133 |
container_issue | 2 |
container_start_page | 127 |
container_title | Paediatrics and Family Medicine |
container_volume | 12 |
creator | Brzęczek, Maciej Słonka, Karina Hyla-Klekot, Lidia |
description | Melatonin, a tryptophan derivative, is synthesised in mammals mainly in the pineal gland. It coordinates the biological clock by regulating the circadian rhythm. Its production is dependent on light and its concentrations change with age. Thanks to its specific chemical structure, melatonin is capable of crossing all biological barriers in the organism and affecting other tissues and cells, both in indirect and direct ways. Its mechanism of action involves binding with membrane receptors, nuclear receptors and intracellular proteins. Melatonin shows antioxidant activity. Moreover, its immunomodulatory and antilipid effects as well as its role in secreting other hormones, such as prolactin, luteinizing hormone, follicle-stimulating hormone, somatotropin, thyroliberin, adrenocorticotropin hormone or corticosteroids, are essential. In the recent years, research studies have been mainly focussed on the potential influence of melatonin on the aetiology and development of various disease entities, such as sleep disorders, gastrointestinal diseases, cancers, psychiatric and neurological conditions, cardiovascular diseases or conditions with bone turnover disorders. Indications for melatonin use in paediatrics are being discussed more and more frequently. Among others, authors debate on its use in dyssomnias in children with neurodevelopmental disorders, such as attention deficit hyperactivity disorder, supportive treatment in febrile seizures and epilepsy as well as potential use in paediatric anaesthesia. The molecular mechanism and broad-spectrum action of melatonin have not been sufficiently researched and its clinical relevance is often underestimated. This hormone is a promising link in achieving alternative therapeutic solutions. |
doi_str_mv | 10.15557/PiMR.2016.0011 |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_crossref_primary_10_15557_PiMR_2016_0011</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2708770040</sourcerecordid><originalsourceid>FETCH-LOGICAL-c240t-7a081bd33dbd40a688c20c818eba04236a35ee939b1192bb9a8f79c4fc7c90b3</originalsourceid><addsrcrecordid>eNot0LtOwzAYBWALgURVOrNG6pz0_32JnRFVXCq1AqHulu04wiiNg5MObLwDb8iT0FCmsxydI32E3CIUKISQq5ewey0oYFkAIF6QGeUCc5CcXpIZSsZzFAyvyWIYggWQinGp6Iwsd741Y-xCl_18fWcm61sf4phiH1z2FtMhdv6GXDWmHfziP-dk_3C_Xz_l2-fHzfpumzvKYcylAYW2Zqy2NQdTKuUoOIXKWwOcstIw4X3FKotYUWsroxpZOd446SqwbE6W59k-xY-jH0b9Ho-pOz1qKkFJCcDh1FqdWy7FYUi-0X0KB5M-NYL-s9CThZ4s9GTBfgH5f1Dk</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2708770040</pqid></control><display><type>article</type><title>Melatonin – a pleiotropic hormone</title><source>Publicly Available Content (ProQuest)</source><creator>Brzęczek, Maciej ; Słonka, Karina ; Hyla-Klekot, Lidia</creator><creatorcontrib>Brzęczek, Maciej ; Słonka, Karina ; Hyla-Klekot, Lidia ; Instytut Fizjoterapii, Wydział Wychowania Fizycznego i Fizjoterapii, Politechnika Opolska, Opole, Polska ; Oddział Chirurgii Urazowo-Ortopedycznej, Zakład Opieki Zdrowotnej, Olesno, Polska</creatorcontrib><description>Melatonin, a tryptophan derivative, is synthesised in mammals mainly in the pineal gland. It coordinates the biological clock by regulating the circadian rhythm. Its production is dependent on light and its concentrations change with age. Thanks to its specific chemical structure, melatonin is capable of crossing all biological barriers in the organism and affecting other tissues and cells, both in indirect and direct ways. Its mechanism of action involves binding with membrane receptors, nuclear receptors and intracellular proteins. Melatonin shows antioxidant activity. Moreover, its immunomodulatory and antilipid effects as well as its role in secreting other hormones, such as prolactin, luteinizing hormone, follicle-stimulating hormone, somatotropin, thyroliberin, adrenocorticotropin hormone or corticosteroids, are essential. In the recent years, research studies have been mainly focussed on the potential influence of melatonin on the aetiology and development of various disease entities, such as sleep disorders, gastrointestinal diseases, cancers, psychiatric and neurological conditions, cardiovascular diseases or conditions with bone turnover disorders. Indications for melatonin use in paediatrics are being discussed more and more frequently. Among others, authors debate on its use in dyssomnias in children with neurodevelopmental disorders, such as attention deficit hyperactivity disorder, supportive treatment in febrile seizures and epilepsy as well as potential use in paediatric anaesthesia. The molecular mechanism and broad-spectrum action of melatonin have not been sufficiently researched and its clinical relevance is often underestimated. This hormone is a promising link in achieving alternative therapeutic solutions.</description><identifier>ISSN: 1734-1531</identifier><identifier>EISSN: 2451-0742</identifier><identifier>DOI: 10.15557/PiMR.2016.0011</identifier><language>eng ; pol</language><publisher>Warsaw: Medical Communications Sp. z o.o</publisher><subject>Biological clocks ; Melatonin ; Neurodevelopmental disorders</subject><ispartof>Paediatrics and Family Medicine, 2016-01, Vol.12 (2), p.127-133</ispartof><rights>2016. This work is published under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c240t-7a081bd33dbd40a688c20c818eba04236a35ee939b1192bb9a8f79c4fc7c90b3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids></links><search><creatorcontrib>Brzęczek, Maciej</creatorcontrib><creatorcontrib>Słonka, Karina</creatorcontrib><creatorcontrib>Hyla-Klekot, Lidia</creatorcontrib><creatorcontrib>Instytut Fizjoterapii, Wydział Wychowania Fizycznego i Fizjoterapii, Politechnika Opolska, Opole, Polska</creatorcontrib><creatorcontrib>Oddział Chirurgii Urazowo-Ortopedycznej, Zakład Opieki Zdrowotnej, Olesno, Polska</creatorcontrib><title>Melatonin – a pleiotropic hormone</title><title>Paediatrics and Family Medicine</title><description>Melatonin, a tryptophan derivative, is synthesised in mammals mainly in the pineal gland. It coordinates the biological clock by regulating the circadian rhythm. Its production is dependent on light and its concentrations change with age. Thanks to its specific chemical structure, melatonin is capable of crossing all biological barriers in the organism and affecting other tissues and cells, both in indirect and direct ways. Its mechanism of action involves binding with membrane receptors, nuclear receptors and intracellular proteins. Melatonin shows antioxidant activity. Moreover, its immunomodulatory and antilipid effects as well as its role in secreting other hormones, such as prolactin, luteinizing hormone, follicle-stimulating hormone, somatotropin, thyroliberin, adrenocorticotropin hormone or corticosteroids, are essential. In the recent years, research studies have been mainly focussed on the potential influence of melatonin on the aetiology and development of various disease entities, such as sleep disorders, gastrointestinal diseases, cancers, psychiatric and neurological conditions, cardiovascular diseases or conditions with bone turnover disorders. Indications for melatonin use in paediatrics are being discussed more and more frequently. Among others, authors debate on its use in dyssomnias in children with neurodevelopmental disorders, such as attention deficit hyperactivity disorder, supportive treatment in febrile seizures and epilepsy as well as potential use in paediatric anaesthesia. The molecular mechanism and broad-spectrum action of melatonin have not been sufficiently researched and its clinical relevance is often underestimated. This hormone is a promising link in achieving alternative therapeutic solutions.</description><subject>Biological clocks</subject><subject>Melatonin</subject><subject>Neurodevelopmental disorders</subject><issn>1734-1531</issn><issn>2451-0742</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><recordid>eNot0LtOwzAYBWALgURVOrNG6pz0_32JnRFVXCq1AqHulu04wiiNg5MObLwDb8iT0FCmsxydI32E3CIUKISQq5ewey0oYFkAIF6QGeUCc5CcXpIZSsZzFAyvyWIYggWQinGp6Iwsd741Y-xCl_18fWcm61sf4phiH1z2FtMhdv6GXDWmHfziP-dk_3C_Xz_l2-fHzfpumzvKYcylAYW2Zqy2NQdTKuUoOIXKWwOcstIw4X3FKotYUWsroxpZOd446SqwbE6W59k-xY-jH0b9Ho-pOz1qKkFJCcDh1FqdWy7FYUi-0X0KB5M-NYL-s9CThZ4s9GTBfgH5f1Dk</recordid><startdate>20160101</startdate><enddate>20160101</enddate><creator>Brzęczek, Maciej</creator><creator>Słonka, Karina</creator><creator>Hyla-Klekot, Lidia</creator><general>Medical Communications Sp. z o.o</general><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope></search><sort><creationdate>20160101</creationdate><title>Melatonin – a pleiotropic hormone</title><author>Brzęczek, Maciej ; Słonka, Karina ; Hyla-Klekot, Lidia</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c240t-7a081bd33dbd40a688c20c818eba04236a35ee939b1192bb9a8f79c4fc7c90b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng ; pol</language><creationdate>2016</creationdate><topic>Biological clocks</topic><topic>Melatonin</topic><topic>Neurodevelopmental disorders</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Brzęczek, Maciej</creatorcontrib><creatorcontrib>Słonka, Karina</creatorcontrib><creatorcontrib>Hyla-Klekot, Lidia</creatorcontrib><creatorcontrib>Instytut Fizjoterapii, Wydział Wychowania Fizycznego i Fizjoterapii, Politechnika Opolska, Opole, Polska</creatorcontrib><creatorcontrib>Oddział Chirurgii Urazowo-Ortopedycznej, Zakład Opieki Zdrowotnej, Olesno, Polska</creatorcontrib><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>ProQuest Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Publicly Available Content (ProQuest)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><jtitle>Paediatrics and Family Medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Brzęczek, Maciej</au><au>Słonka, Karina</au><au>Hyla-Klekot, Lidia</au><aucorp>Instytut Fizjoterapii, Wydział Wychowania Fizycznego i Fizjoterapii, Politechnika Opolska, Opole, Polska</aucorp><aucorp>Oddział Chirurgii Urazowo-Ortopedycznej, Zakład Opieki Zdrowotnej, Olesno, Polska</aucorp><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Melatonin – a pleiotropic hormone</atitle><jtitle>Paediatrics and Family Medicine</jtitle><date>2016-01-01</date><risdate>2016</risdate><volume>12</volume><issue>2</issue><spage>127</spage><epage>133</epage><pages>127-133</pages><issn>1734-1531</issn><eissn>2451-0742</eissn><abstract>Melatonin, a tryptophan derivative, is synthesised in mammals mainly in the pineal gland. It coordinates the biological clock by regulating the circadian rhythm. Its production is dependent on light and its concentrations change with age. Thanks to its specific chemical structure, melatonin is capable of crossing all biological barriers in the organism and affecting other tissues and cells, both in indirect and direct ways. Its mechanism of action involves binding with membrane receptors, nuclear receptors and intracellular proteins. Melatonin shows antioxidant activity. Moreover, its immunomodulatory and antilipid effects as well as its role in secreting other hormones, such as prolactin, luteinizing hormone, follicle-stimulating hormone, somatotropin, thyroliberin, adrenocorticotropin hormone or corticosteroids, are essential. In the recent years, research studies have been mainly focussed on the potential influence of melatonin on the aetiology and development of various disease entities, such as sleep disorders, gastrointestinal diseases, cancers, psychiatric and neurological conditions, cardiovascular diseases or conditions with bone turnover disorders. Indications for melatonin use in paediatrics are being discussed more and more frequently. Among others, authors debate on its use in dyssomnias in children with neurodevelopmental disorders, such as attention deficit hyperactivity disorder, supportive treatment in febrile seizures and epilepsy as well as potential use in paediatric anaesthesia. The molecular mechanism and broad-spectrum action of melatonin have not been sufficiently researched and its clinical relevance is often underestimated. This hormone is a promising link in achieving alternative therapeutic solutions.</abstract><cop>Warsaw</cop><pub>Medical Communications Sp. z o.o</pub><doi>10.15557/PiMR.2016.0011</doi><tpages>7</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1734-1531 |
ispartof | Paediatrics and Family Medicine, 2016-01, Vol.12 (2), p.127-133 |
issn | 1734-1531 2451-0742 |
language | eng ; pol |
recordid | cdi_crossref_primary_10_15557_PiMR_2016_0011 |
source | Publicly Available Content (ProQuest) |
subjects | Biological clocks Melatonin Neurodevelopmental disorders |
title | Melatonin – a pleiotropic hormone |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-07T22%3A11%3A25IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Melatonin%20%E2%80%93%20a%20pleiotropic%20hormone&rft.jtitle=Paediatrics%20and%20Family%20Medicine&rft.au=Brz%C4%99czek,%20Maciej&rft.aucorp=Instytut%20Fizjoterapii,%20Wydzia%C5%82%20Wychowania%20Fizycznego%20i%20Fizjoterapii,%20Politechnika%20Opolska,%20Opole,%20Polska&rft.date=2016-01-01&rft.volume=12&rft.issue=2&rft.spage=127&rft.epage=133&rft.pages=127-133&rft.issn=1734-1531&rft.eissn=2451-0742&rft_id=info:doi/10.15557/PiMR.2016.0011&rft_dat=%3Cproquest_cross%3E2708770040%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c240t-7a081bd33dbd40a688c20c818eba04236a35ee939b1192bb9a8f79c4fc7c90b3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2708770040&rft_id=info:pmid/&rfr_iscdi=true |